csirt@kutim:~/threat-intel/cve/CVE-2026-30821

Katalog CVE

CVSS 9.8 · Critical EPSS 0,93%

Kerentanan Unrestricted Upload of File with Dangerous Type pada flowiseai flowise. Skor CVSS 3.1 9.8 (Critical) menurut NVD.

Deskripsi (NVD)

Flowise is a drag & drop user interface to build a customized large language model flow. Prior to version 3.0.13, the /api/v1/attachments/:chatflowId/:chatId endpoint is listed in WHITELIST_URLS, allowing unauthenticated access to the file upload API. While the server validates uploads based on the MIME types defined in chatbotConfig.fullFileUpload.allowedUploadFileTypes, it implicitly trusts the client-provided Content-Type header (file.mimetype) without verifying the file's actual content (magic bytes) or extension (file.originalname). Consequently, an attacker can bypass this restriction by spoofing the Content-Type as a permitted type (e.g., application/pdf) while uploading malicious scripts or arbitrary files. Once uploaded via addArrayFilesToStorage, these files persist in backend storage (S3, GCS, or local disk). This vulnerability serves as a critical entry point that, when chained with other features like static hosting or file retrieval, can lead to Stored XSS, malicious file hosting, or Remote Code Execution (RCE). This issue has been patched in version 3.0.13.

Rincian

Terbit di NVD
7 Maret 2026
Terakhir diubah
17 Juni 2026
Status NVD
Analyzed
CVSS 3.1
9.8 (Critical), sumber NVD
CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:H/A:H · uraikan di kalkulator
Jenis kelemahan (CWE)
CWE-434: Unrestricted Upload of File with Dangerous Type
EPSS (30 hari)
0,93% peluang dieksploitasi; lebih tinggi dari 59,7% CVE lain

Produk dan versi terdampak

VendorProdukVersi terdampak
flowiseai flowise Semua versi sebelum 3.0.13

> Data dari konfigurasi CPE di NVD.

Referensi dan perbaikan

Sumber: NVD · CVE.org · EPSS. Halaman ini disusun otomatis dari data tersebut; pembaruan terakhir 5 Okt 2026, 20:11 WITA. Kalau sistem di Perangkat Daerah memakai produk ini dan butuh bantuan, laporkan lewat kanal pelaporan.